ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
506U78 in Treating Patients With Refractory Hematologic Cancer

This study is ongoing, but not recruiting participants.
Study NCT00002970.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Leukemia
Lymphoma
2 More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
3 Interventions listed in this trial
cytarabine
methotrexate
nelarabine
therapeutic hydrocortisone
4 Additional drug interventions recognized in this trial
Cortisol succinate
Hydrocortisone
Hydrocortisone acetate
5 More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Anti-Infective Agents
Anti-Inflammatory Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antirheumatic Agents
Antiviral Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
6 Sponsors listed in this trial
Pediatric Oncology Group
National Cancer Institute (NCI)
Children's Cancer Group




Links to all studies - primarily for crawlers